Bioenergetics and glutamate excitotoxicity

Progress in Neurobiology

Volumn 48, Issue 6, 1996, Pages 613-634

  Greene, James G ^a   Greenamyre, J Timothy ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; EXCITOTOXIN; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOENERGY; BRAIN METABOLISM; HISTOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029992108     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-0082(96)00006-8     Document Type: Review

References (270)

1. 2+ signal transduction. J. Biol. Chem. 267, 13361-13368.
2. Abele, A. E. and Miller, R. J. (1990) Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons. Neurosci. Lett. 115, 195-200.
3. Aizenman, E., Lipton, S. A. and Loring, R. H. (1989) Selective modulation of NMDA responses by reduction and oxidation. Neuron 2, 1257-1263.
4. Albers, G. W., Goldberg, M. P. and Choi, D. W. (1989) N-methyl-D-aspartate antagonists: ready for clinical trial in ischemia?. Ann. Neurol. 25, 398-403.
5. Albin, R. L. and Greenamyre, J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42, 733-738.
6. Aleppo, G., Pisani, A., Copani, A., Bruno, V., Aronica, E., D'Agata, V., Canonico, P. L. and Nicoletti, F. (1992) Metabotropic glutamate receptors and neuronal toxicity. Adv. Exp. Med. Biol. 318, 137-145.
7. Alston, T. A. (1977) 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA 74, 3767-3771.
8. Anderson, J. J., Bravi, D., Ferrari, R., Davis, T. L., Baronti, F., Chase, T. N. and Dagani, F. (1993) No evidence for altered muscle mitochondrial function in Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 56, 477-480.
9. 2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res. 548, 322-325.
10. Angel, R. and Greenamyre, J. T. (1995) Chronic treatment with thioctic acid does not protect against malonate toxicity in vivo. Neurosci. Lett. 196, 125-127.
11. + transport in canine brain. Stroke 12, 726-730.
12. Barbour, B., Brew, H. and Attwell, D. (1988) Electrogenic glutamate uptake in glial cells is activated by intracellular potassium. Nature 335, 433-435.
13. Beal, M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 31, 119-130.
14. Beal, M. F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
15. Beal, M.F., Brouillet, E., Jenkins, B.G., Ferrante, R.J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R. and Hyman, B.T. (1993a) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial 3-nitropropionic acid. J. Neurosci. 13, 4181-4192.
16. Beal, M.F., Brouillet, E., Jenkins, B., Henshaw, R., Rosen, B. and Hyman, B.T. (1993b) Age-dependent striatal lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 1147-1150.
17. Beal, M. F., Ferrante, R. J., Henshaw, R., Matthews, R. T., Chan, P. H., Kowall, N. W., Epstein, C. J. and Schulz, J. B. (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide transgenic mice. J. Neurochem. 65, 919-922.
18. Beal, M.F., Hyman, B.T. and Koroshetz, W. (1993c) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
19. Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J. and Martin, J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-172.
20. Beal, M. F., Swartz, K. J., Hyman, B. T., Storey, E., Finn, S. F. and Koroshetz, W. (1991) Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism. J. Neurochem. 57, 1068-1073.
21. + channels: a novel strategy to reduce the deleterious effects of anoxia. In: Excitatory Amino Acids and Neuronal Plasticity, pp. 481-489. Ed. Y. Ben-Ari. Plenum Press, New York.
22. Benveniste, H., Drejer, J., Schousboc, A. and Diemer, N. H. (1984) Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral micro-dialysis. J. Neurochem. 43, 1369-1374.
23. Benson, D. F., Kuhl, D. E., Hawkins, R. A., Phelps, M. E., Cummings, J. L. and Tsai, S. Y. (1983) The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40, 711-714.
24. Bettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E. S., Moll, C., Borgmeyer, U., Hollman, M. and Heinemann, S. (1990) Cloning of a novel glutamate-receptor subunit, GluR5: expression in the central nervous system in development. Neuron 5, 583-595.
25. Bettler, B., Egebjerg, J., Sharma, G., Pecht, G., Hermans-Borgmeyer, I., Moll, C., Stevens, C. F. and Heinemann, S. (1992) Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit. Neuron 8, 257-265.
26. Bindoff, L. A., Birch-Machin, M. A., Cartlidge, N. E., Parker, W. D., Jr. and Turnbull, D. M. (1991) Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104, 203-208.
27. Bird, E. D., Gale, J. S. and Spokes, E. G. (1977) Huntington's chorea: post mortem activity of enzymes involved in cerebral glucose metabolism. J. Neurochem. 29, 539-545.
28. Blass, J. P., Baker, A. C., Ko, L. and Black, R. S. (1990) Induction of Alzheimer's antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47, 864-869.
29. Blaustein, M. P. (1988) Calcium transport and buffering in neurons. Trends Neurosci. 10, 438-443.
30. Blaustein, M. P., Goldman, W. F., Fontana, G., Krueger, B. K., Santiago, E. M., Steele, T. E., Weiss, D. N. and Yarowsky, P. J. (1991) Physiological roles of the sodium-calcium exchanger in nerve and muscle. Ann. NY Acad. Sci. 639, 254-275.
31. Boening, J. A., Kass, I. S., Cottrell, J. E. and Chambers, G. (1989) The effect of blocking sodium influx on anoxic damage in the rat hippocampal slice. Neuroscience 33, 263-268.
32. Bondy, S. C. and LeBel, C. P. (1993) The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Rad. Biol. Med. 14, 633-642.
33. Bowling, A. C. and Beal, M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
34. Bredt, D. S. and Snyder, S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86, 9030-9033.
35. Bredt, D. S. and Snyder, S. H. (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
36. Brennan, W. A., Bird, E. D. and Aprille, J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
37. Brines, M. L. and Robbins, R. J. (1992) Inhibition of α1/α2 sodium pump isoforms potentiates glutamate neurotoxicity. Brain Res. 591, 94-102.
38. Brorson, J. R., Bleakman, D., Chard, P. S. and Miller, R. J. (1992) Calcium directly permeates kainate/α-amino-3-hydroxy-5-methyl-4-isoxasole-propionic acid receptors in cultured cerebellar Purkinje's neurons. Mol. Pharmacol. 41, 603-608.
39. +-ATPase on the membrane potentials and neurotransmitter efflux in rat brain slices. Brain Res. 334, 125-137.
40. Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroywillig, A., Kowall, N. W. and Beal, M. F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. USA 92, 7105-7109.
41. Brouillet, E., Hyman, B. T., Jenkins, B. G., Henshaw, D. R., Schulz, J. B., Sodhi, P., Rosen, B. R. and Beal, M. F. (1994) Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Exp. Neurol. 129, 175-182.
42. Brouillet, E., Jenkins, B.G., Hyman, B.T., Ferrante, R., Kowall, N.W., Srivastava, R., Roy, D.S., Rosen, B.R. and Beal, M.F. (1993a) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
43. Brouillet, E.P., Shinobu, L., McGarvey, U., Hochberg, F. and Beal, M.F. (1993b) Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120, 89-94.
44. Buchan, A. M., Lesiuk, H., Barnes, K. A., Li, H., Huang, Z.-G., Smith, K. E. and Xue, D. (1990) AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?. Stroke 24, 1148-1152.
45. Burnashev, N., Khordorva, A., Jonas, P., Helm, P. J., Wisden, W., Monyer, H., Seeburg, P. H. and Sakmann, B. (1992) Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. Science 256, 1566-1570.
46. Butterworth, J., Yates, C. M. and Reynolds, G. P. (1985) Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase, and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J. Neurol. Sci. 67, 161-171.
47. Cao, X. and Phillis, J. W. (1994) α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644, 267-272.
48. Carafoli, E. (1991) The calcium pumping ATAase of the plasma membrane. A. Rev. Physiol. 53, 531-547.
49. Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W. and Di Monte, D. (1991) Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57, 348-351.
50. Cheng, B. and Mattson, M. P. (1992) Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp. Neurol. 117, 114-123.
51. Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
52. Choi, D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
53. Ciabarra, A. M., Sullivan, J. M., Gahn, L. G., Pecht, G., Heinemann, S. and Sevarino, K. A. (1995) Cloning and characterization of c-1 : a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 15, 6498-6508.
54. Cousin, M. A., Nicholls, D. G. and Pocock, J. M. (1995) Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain. J. Neurochem. 64, 2097-2104.
55. Coyle, J. T., Murphy, T. H., Puttfarcken, P. S., Lyons, E. W. and Vornov, J. J. (1991) The non-excitatory mechanisms of glutamate induced neurotoxicity. Epilep. Res. 10, 41-48.
56. Coyle, J. T. and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
57. Coyle, J. T. and Schwarcz, R. (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263, 244-246.
58. + gradients, and neurotransmitter amino acid levels in isolated rat brain synaptosomes. J. Neurochem. 49, 1229-1240.
59. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S. and Snyder, S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
60. De Boni, U. and Crapper-McLachlan, D. R. (1985) Controlled induction of paired helical filaments of the Alzheimer's type in cultured human neurons, by glutamate and aspartate. J. Neurol. Sci. 68, 105-118.
61. Dingledine, R. (1983) N-methyl aspartate activates voltage-dependent calcium conductance in rat hippocampal pyramidal cells. J. Physiol. (Lond.) 343, 385-406.
62. Dingledine, R., Boland, R. M., Chamberlin, N. L., Kawasaki, K., Kleckner, N. W., Traynelis, S. F. and Verdoon, T. A. (1988) Amino acid receptors and uptake systems in the mammalian central nervous system. Crit. Rev. Neurobiol. 4, 1-96.
63. Duara, R., Grady, C., Haxby, J., Ingvar, D., Sokoloff, L., Margolin, R. A., Manning, R. G., Cutler, N. R. and Rapoport, S. I. (1984) Human brain glucose utilization and cognitive function in relation to age. Ann. Neurol. 16, 702-713.
64. Dubinsky, J. M. and Rothman, S. M. (1991) Intracellular calcium concentration during "chemical hypoxia" and excitotoxic neuronal injury. J. Neurosci. 11, 2545-2551.
65. Duchen, M. R., Valdeolomillos, M., O'Neill, S. C. and Eisner, D. A. (1990) Effects of metabolic blockade on the regulation of intracellular calcium in dissociated mouse sensory neurones. J. Physiol. (Lond.) 424, 411-426.
66. Dugan, L. L., Sensi, S. L., Canzoniero, L. M. T., Handran, S. D., Rothman, S. M., Lin, T.-S., Goldberg, M. P. and Choi, D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
67. Dumuis, A., Sebben, M., Haynes, L., Pin, J. P. and Bockaert, J. (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 68-70.
68. Duvoisin, R. M., Zhang, C. and Ramonell, K. (1995) A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. J. Neurosci. 15, 3075-3083.
69. +: implications for neurodegeneration. J. Neurochem. 63, 584-591.
70. Dykens, J. A., Stern, A. and Trenkner, E. (1987) Mechanisms of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49, 1222-1228.
71. Egebjerg, J., Bettler, B., Hermans-Borgmeyer, I. and Heinemann, S. (1991) Cloning of a cDNA for a glutamate-receptor subunit activated by kainate but not AMPA. Nature 351, 745-748.
72. Eimerl, S. and Schramm, M. (1994) The quantity of calcium that appears to induce neuronal death. J. Neurochem. 62, 1223-1226.
73. 2+ after toxic NMDA-receptor activity. J. Neurochem. 65, 739-743.
74. Erecinska, M. and Dagani, F. (1990) Relationships between the neuronal sodium/potassium pump and energy metabolism. J. Gen. Physiol. 95, 591-616.
75. Erecínska, M. and Silver, I. A. (1994) Ions and energy in mammalian brain. Prog. Neurobiol. 43, 37-71.
76. Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E. and Beal, M. F. (1993) Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol. 119, 46-71.
77. Flatman, J. A., Schwindt, P. C., Crill, W. E. and Stafstrom, C. E. (1983) Multiple actions of N-methyl-D-aspartate on cat neocortical neurons in vitro. Brain Res. 266, 169-173.
78. Foster, A. C. and Wong, E. H. F. (1987) The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br. J. Pharmacol. 91, 403-409.
79. Francis, A. and Pulsinelli, W. (1982) The response of GABAergic and cholinergic neurons to transient cerebral ischemia. Brain Res. 243, 271-278.
80. Gibson, R. E., Burns, H. D., Thorpe, H. H., Eng. W.-S., Ransom, R. and Solomon, H. (1992) In vivo binding and autoradiographic imaging of ( + )-3-[125I]iodo-MK-801 to the NMDA receptor-channel complex in rat brain. Nucl. Med. Biol. 19, 319-326.
81. Gibson, G. E., Sheu, K.-F. R., Blass, J. P., Baker, A., Carlson, K. C., Harding, B. and Perrino, P. (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45, 836-840.
82. Giffard, R. G., Monyer, H., Christine, C. W. and Choi, D. W. (1990) Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res. 506, 339-342.
83. Gill, D. L., Grollman, E. F. and Kohn, L. D. (1981) Calcium transport mechanisms in membrane vessicles from guinea pig brain synaptosomes. J. Biol. Chem. 256, 184-192.
84. Globus, M. Y.-T., Busto, R., Dietrich, W. D. and Ginsberg, M. D. (1988) Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51, 1455-1464.
85. Greenamyre, J. T., Young, A. B., and Penney, J. B., Jr (1992) NMDA receptor abnormalities in neurodegenerative disorders. In: New Leads and Targets in Drug Research, Alfred Benzon Symposium 33, pp. 304-314. Eds. P. Krogsgaard-Larsen, S.B. Christensen and H. Kofod. Munksgaard, Copenhagen.
86. Greenamyre, J. T., Penney, J. B., Young, A. B., D'Amato, C. J., Hicks, S. P. and Shoulson, I. (1986) Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227, 1496-1499.
87. Greenamyre, J. T. and Porter, R. H. P. (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44, S7-S13.
88. Greenamyre, J. T., Garcia-Osuna, M. and Greene, J. G. (1994) The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of sthatum. Neurosci. Lett. 171, 17-20.
89. Greene, J. G., Porter, R. H. P., Eller, R. V. and Greenamyre, J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61, 1151-1154.
90. Greene, J.G. and Greenamyre, J.T. (1995a) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 430-436.
91. Greene, J.G. and Greenamyre, J.T. (1995b) Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 2332-2338.
92. Greene, J. G. and Greenamyre, J. T. (1996a) Bioenergetics and excitotoxicity: the weak excitotoxic hypothesis. In: Neuroprotective Approaches to the Treatment of Parkinson's Disease and Other Neurodegenerative Disorders. Eds. C. W. Olanow, P. Jenner and M. Youdim. Academic Press, London, pp. 125-142.
93. Greene, J.G. and Greenamyre, J.T. (1996b) Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo. J. Neurochem. 66, 637-643.
94. Gunasekar, P. G., Kanthasamy, A. G., Borowitz, J. L. and Isom, G. E. (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J. Neurochem. 65, 2016-2021.
95. Gunter, T. E., Gunter, K. K., Sheu, S.-S. and Gavin, C. E. (1994) Mitochondrial calcium transport. Am. J. Physiol. 267, C313-C339.
96. Gunter, T. E. and Pfeiffer, D. R. (1990) Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258, C755-C786.
97. Haddad, G. G. and Jiang, C. (1993) Mechanisms of anoxia-induced depolarization in brainstem neurons: in vitro current and voltage clamp studies in the adult rat. Brain Res. 625, 261-268.
98. Hagberg, H., Lehmann, A., Sandberg, M., Nystrom, B., Jacobsen, I. and Hamberger, A. (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra-to extracellular compartments. J. Cereb. Blood Flow Metab. 5, 413-419.
99. Halliwell, B. and Gutteridge, J. M. C. (1985) Oxygen radicals and the nervous system. Trends Neurosci. 8, 22-26.
100. 2+ accumulation in cortical cell culture correlates with subsequent neurodegeneration. J. Neurosci. 13, 1993-2000.
101. Hattori, N., Tanaka, M., Ozawa, T. and Mizuno, Y. (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30, 563-571.
102. Haxby, J. V., Grady, C. L., Duara, R., Schlageter, N., Berg, G. and Rapoport, S. I. (1986) Neocortical metabolic abnormalities precede non-memory cognitive deficits in early Alzheimer-type dementia. Arch. Neurol. 43, 882-885.
103. Headley, P. M. and Grillner, S. (1990) Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 11, 205-211.
104. Heffez, D. S. and Passonneau, J. V. (1985) Effect of nimodipine on cerebral metabolism during ischemia and recirculation in the mongolian gerbil. J. Cereb. Blood Flow Metab. 5, 523-528.
105. Henshaw, R., Jenkins, B. G., Schulz, J. B., Ferrante, R. J., Kowall, N. W., Rosen, B. R. and Beal, M. F. (1994) Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Res. 647, 161-166.
106. Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W. and Seeburg, P. H. (1992) The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8, 774-785.
107. Hochster, R. M. and Quastel, J. H., Eds (1963) Metabolic Inhibitors: A Comprehensive Treatise. Academic Press, New York.
108. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853.
109. Hollman, M., O'Shea-Greenfield, A., Rogers, S. W. and Heinemann. S. (1989) Cloning by functional expression of a member of the glutamate receptor family. Nature 342, 643-648.
110. Houamed, K. M., Kuijper, J. L., Gilbert, T. L., Haldeman, B. A., O'Hara, P. J., Mulvihill, E. R., Almers, W. and Augan, F. S. (1991) Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain. Science 252, 1318-1321.
111. Huber, G. and Matus, A. (1981) Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. J. Neurosci. 4, 151-160.
112. Ikeda, M., Nakazawa, T., Abe, K., Kaneko, T. and Yamatsu, K. (1989) Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent - in vitro and in vivo. Neurosci. Lett. 96, 202-206.
113. Ikeda, M., Yoshida, S., Busto, R., Santiso, M., Martinez, E. and Ginsberg, M. D. (1987) Cerebral phosphoinositide and energy metabolism during and after insulin-induced hypoglycemia. J. Neurochem. 49, 100-106.
114. Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M. and Nakanishi, S. (1993) Molecular characterization of the N-methyl-D-aspartate-receptor subunits. J. Biol. Chem. 268, 2836-2843.
115. Iwangoff, P., Armbruster, R., Enz, A. and Meier-Ruge, W. (1980) Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech. Ageing. Dev. 14, 203-209.
116. Jacobsen, I., Hagberg, H., Sandberg, M. and Hamberger, A. (1986) Ouabain-induced changes in extracellular aspartate, glutamate, and GABA levels in the rabbit olfactory bulb in vivo. Neurosci. Lett. 64, 211-215.
117. Jenkins, B., Koroshetz, W., Beal, M. F. and Rosen, B. R. (1993) Evidence for an energy metabolism defect in Huntington's disease using localized proton spectroscopy. Neurology 43, 2689-2695.
118. Johnson, J. W. and Ascher, P. (1987) Glycine potentiates the NMDA response in cultured mouse neurons. Nature 325, 529-533.
119. Jones-Humble, S. A., Morgan, P. F. and Cooper, B. R. (1994) The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP model of Parkinson's disease. Life Sci. 54, 245-252.
120. Kanai, Y., Smith, C. P. and Hediger, M. A. (1993) The elusive transporters with a high affinity for glutamate. Trends Neurosci. 16, 359-365.
121. Katsura, K., Kristián, T. and Siesjö, B. K. (1994) Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem. Soc. Trans. 22, 991-996.
122. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemeia and anoxia. Neuroscience 27, 175-182.
123. Kauppinen, R. A., Sihra, T. S. and Nicholls, D. G. (1987) Aminooxyacetic acid inhibits the malate - aspartate shuttle in isolated nerve terminals and prevents the mitochondria from using glycolytic substrates. Biochim. Biophys. Acta 930, 173-178.
124. Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B. and Seeburg, P. H. (1990) A family of AMPA-selective glutamate receptors. Science 249, 556-560.
125. Kiedrowski, L., Brooker, G., Costa, E. and Wroblewski, J. T. (1994) Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12, 295-300.
126. Kiedrowski, L. and Costa, E. (1995) Glutamate-induced destabilization of intracellular calcium concentration homeostasis in cultured cerebellar granule cells: role of mitochondria in calcium buffering. Mol. Pharmacol. 47, 140-147.
127. Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L. J., Wilson, J. M., DiStefano, L. M. and Nobrega, J. N. (1992) Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779.
128. Kleckner, N. and Dingledine, R. (1988) Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241, 835-837.
129. Koch, R. A. and Barish, M. E. (1994) Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J. Neurosci. 14, 2585-2593.
130. Koh, J.-Y., Yang, L. L. and Cotman, C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
131. Kopin, I. J. and Markey, S. P. (1988) MPTP toxicity: implications for research in Parkinson's disease. Ann. Rev. Neurosci. 11, 81-96.
132. Koroshetz, W. J., Jenkins, B. G., Beal, M. F. and Rosen, B. R. (1992) Localized proton NMR-spectroscopy in patients with Huntington's disease (HD) demonstrates abnormal lactate levels in occipital cortex: evidence for compromised metabolism in HD. Neurology 42, 319.
133. Krige, D., Carroll, M. T., Cooper, J. M., Marsden, C. D. and Schapira, A. H. V. (1992) Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 32, 782-788.
134. Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, J., Riege, W. H. and Winter, J. (1982) Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann. Neurol. 12, 425-434.
135. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M. and Mishina, M. (1992) Molecular diversity of the NMDA-receptor channel. Nature 358, 36-41.
136. Kuwert, T., Lange, H. W., Langer, K.-J., Herzog, H., Aulich, A. and Feinendegen, L. E. (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113, 1405-1423.
137. Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
138. Lange, K. W., Loschmann, P.-A., Sofic, E., Burg, M., Horowski, R., Kalveram, K. T., Wachtel, H. and Riederer, P. (1993) The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates. Naunyn Schmeideberg's Arch. Pharmacol. 348, 586-592.
139. Langston, J. W., Ballard, P. A., Tetrud, J. W. and Irwin, I. (1983) Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 219, 979-980.
140. Laurie, D. J. and Seeburg, P. H. (1994) Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14, 3180-3194.
141. Lees, G. J. (1991) Inhibition of sodium-potassium ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Rev. 16, 283-300.
142. Lees, G. J., Lehmann, A., Sandberg, M. and Hamberger, A. (1990) The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus. Neurosci. Lett. 120, 159-162.
143. Lees, G. J. and Leong, W. (1994) Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase. Brain Res. 649, 225-233.
144. 2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 112, 338-342.
145. Lin, F. H., Lin, R., Wisniewski, H. M., Hwang, Y. W., Grundke-Iqbal, I., Healy-Louie, G. and Iqbal, K. (1992) Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem. Biophys. Res. Commun. 182, 238-246.
146. Lipton, P. and Lobner, D. (1990) Mechanisms of intracellular calcium accumulation in the CA1 region of rat hippocampus during anoxia in vitro. Stroke 21, III60-III64.
147. Lipton, P. and Whittingham, T. S. (1982) Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in the in vitro guinea-pig hippocampus. J. Physiol. (Lond.) 325, 51-65.
148. Ludolph, A. C., Seelig, M., Ludolph, A. G., Subri, M. I. and Spencer, P. S. (1992) Cellular energy deficits and excitotoxic lesions induced by 3-nitropropionic acid in vitro. Neurodegeneration 1, 155-161.
149. MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J. and Barker, J. L. (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321, 519-522.
150. Madl, J. E. and Burgesser, K. (1993) Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J. Neurosci. 13, 4429-4444.
151. Majewska, M. D., Bell, J. A. and London, E. D. (1990) Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res. 537, 328-332.
152. Mann, D. M. A., Yates, P. O. and Marcyniuk, B. (1986) A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 49, 310-312.
153. Mann, V. M., Cooper, J. M., Javoy-Agid, F., Agid, Y., Jenner, P. and Schapira, A. H. R. (1990) Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336, 749.
154. Mann, V. M., Cooper, J. M., Krige, D., Daniel, S. E., Schapira, A. H. and Marsden, C. D. (1992) Brain, skeletal muscle, and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115, 333-342.
155. Maragos, W.F. and Silverstein, F.S. (1995a) Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. J. Neurochem. 64, 2362-2365.
156. Maragos, W.F. and Silverstein, F.S. (1995b) The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum. Brain Res. Dev. Brain Res. 88, 117-121.
157. Marey-Semper, I., Gelman, M. and Lévi-Strauss, M. (1995) A selective toxicity toward cultured mesencephalic dopaminergic neurons in induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15, 5912-5918.
158. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
159. Massieu, L., Morales-Villagrán, A. and Tapia, R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64, 2262-2272.
160. Mastrogiacomo, F., Bergeron, C. and Kish, J. J. (1993) Brain alpha-ketoglutarate complex activity in Alzheimer's disease. J. Neurochem. 61, 2007-2014.
161. Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R. and Nakanishi, S. (1991) Sequence and expression of a metabotropic glutamate receptor. Nature 349, 760-765.
162. Mata, M., Fink, D. J., Gainer, H., Smith, C. B., Davidsen, L., Savaki, H., Schwartz, W. J. and Sokoloff, L. (1980) Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem. 34, 213-215.
163. Mattson, M. P. (1988) Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. Rev. 13, 179-212.
164. 2+ influx in cultured hippocampal neurons. Neuron 4, 105-117.
165. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
166. Mattson, M. P., Dou, P. and Kater, S. B. (1988) Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8, 2087-2100.
167. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J. 3, 2519-2526.
168. Mazziotta, J. C., Phelps, M. E., Pahl, J. I., Huang, S.-C., Baxter, L. R., Riege, W. H., Hoffman, J. M., Kuhl, D. E., Lento, A. B., Wapenski, J. A. and Markham, C. H. (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N. Engl. J. Med. 316, 356-362.
169. McDonald, J. W. and Schoepp, D. D. (1993) Aminoxyacetic acid produces excitotoxic brain injury in neonatal rats. Brain Res. 624, 239-244.
170. McGeer, E. G. and McGeer, P. L. (1976) Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids.
171. 2+. J. Neurochem. 56, 86-94.
172. Meguro, H., Mori, H., Araki, K., Kushiya, E., Kutsuwada, T., Yamazaki, M., Kumanishi, T., Arakawa, M., Sakimura, K. and Mishina, M. (1992) Functional characterization of a heteromeric NMDA-receptor channel expressed from cloned cDNAs. Nature 357, 70-74.
173. Mehraein, P., Yamada, M. and Tarnowska-Dziduszko, E. (1975) Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia. Adv. Neurol. 12, 453-458.
174. Messam, C. A., Greene, J. G., Greenamyre, J. T. and Robinson, M. B. (1995) Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids. Brain Res. 684, 221-224.
175. Mizuno, Y., Suzuki, K., Sone, N. and Saitoh, T. (1988) Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo. Neurosci. Lett. 91, 349-353.
176. Monyer, H., Sprengal, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B. and Seeburg, P. H. (1992) Heteromeric NMDA receptors: molecluar and functional distinction of subtypes. Science 256, 1217-1221.
177. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N. and Nakanishi, S. (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37.
178. Morris, R. G. M., Davis, S. and Butcher, S. P. (1990) Hippocampal synaptic plasticity and NMDA receptors: a role in information storage?. Phil. Trans. R. Soc. Lond. B 329, 187-204.
179. Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L. and Coyle, J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
180. Murphy, T. H., Schnaar, R. L. and Coyle, J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine transport. FASEB J. 4, 1624-1633.
181. Mutisya, E. E., Bowling, A. C. and Beal, M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184.
182. Naito, S. and Ueda, T. (1983) Adenosine triphosphate-dependent uptake of glutamate into protein I-associated vesicles. J. Biol. Chem. 258, 696-699.
183. Naito, S. and Ueda, T. (1985) Characterization of glutamate uptake into synaptic vesicles. J. Neurochem. 44, 99-109.
184. Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N. and Nakanishi, S. (1993) Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J. Biol. Chem. 268, 11868-11873.
185. Nakanishi, S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603.
186. Nicklas, W. J. (1986) Glia-neuronal inter-relationships in the metabolism of excitatory amino acids. In: Excitatory Amino Acids, pp. 57-66. Eds P. J. Roberts, J. Storm-Mathisen and H. F. Bradford. Macmillan, London.
187. Nicklas, W. J., Vyas, I. and Heikkila, R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
188. 2+ and cell death. Ann. NY Acad. Sci. 648, 17-27.
189. Novelli, A., Reilly, J. A., Lysko, P. G. and Henneberry, R. C. (1988) Glutamate becomes neurotoxic via the NMDA receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
190. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. and Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
191. Okamoto, N., Hori, S., Akazawa, C., Hayashi, Y., Shigemoto, K., Mizuno, N. and Nakanishi, S. (1994) Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J. Biol. Chem. 269, 1231-1236.
192. Oliver, C. N., Starke, R. P., Stadtman, E. R., Liu, G., Carney, J. M. and Floyd, R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87, 5144-5147.
193. Olney, J. W., Ho, O. L. and Rhee, V. (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14, 61-76.
194. Parker, W.D., Jr., Boyson, S.J., Luder, A.S. and Parks, J.K. (1990a) Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurol. 40, 1231-1234.
195. Parker, W. D., Jr., Boyson, S. J. and Parks, J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
196. Parker, W.D., Jr., Filley, C.M. and Parks, J.K. (1990b) Cytochrome oxidase deficiency in Alzheimer's disease. Neurol. 40, 1302-1303.
197. Parker, W. D., Mahr, N. J., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A. and Cullum, C. M. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086-1090.
198. Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K. and Powell, T. P. S. (1985) Anatomical correlates of the distribution of the pathological changes in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 82, 4531-4534.
199. Pin, J. P. and Duvoisin, R. (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26.
200. Prehn, J. H. M., Karkoutly, C., Nuglisch, J., Peruche, B. and Krieglstein, J. (1992) Dihydrolipoate reduces neuronal injury after cerebral ischemia. J. Cereb. Blood Flow Metab. 12, 78-87.
201. Pumain, R., Kurcewicz, I. and Louvel, J. (1986) Ionic changes induced by excitatory amino acids in the rat cerebral cortex. Can. J. Physiol. (Lond.) Pharmacol. 65, 1067-1077.
202. Pulsinelli, W. A. and Cooper, A. J. L. (1989) Metabolic encephalopathies and coma. In: Basic Neurochemistry, pp. 765-781. Eds G. Siegel, B. Agranoff, R. W. Albers and P. Molinoff. Raven Press, New York.
203. +/H + exchanger. J. Biol. Chem. 266, 2739-2745.
204. -) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56, 1184-1190.
205. Randall, R. D. and Thayer, S. A. (1990) Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J. Neurosci. 12, 1882-1895.
206. Riepe, M. W., Hori, N., Ludolph, A. C. and Carpenter, D. O. (1995) Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience 64, 91-97.
207. Ritchie, J. M. and Straub, R. W. (1980) Oxygen consumption and phosphate efflux in mammalian non-myelinated nerve fibers. J. Physiol. (Lond.) 304, 109-121.
208. Rothman, S. M. (1992) Excitotoxins: possible mechanisms of action. Ann. NY Acad. Sci. 648, 132-139.
209. Rothman, S. M. and Olney, J. W. (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-301.
210. Sacaan, A. L. and Schoepp, D. D. (1992) Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139, 77-82.
211. 2+ -independent release of glutamate during anoxia in isolated nerve terminals (synaptosomes). J. Neurochem. 50, 1322-1324.
212. Sanchez-Prieto, J., Sihra, T. S. and Nicholls, D. G. (1987) Characterization of the exocytotic release of glutamate from guinea-pig cerebral cortical synaptosomes. J. Neurochem. 49, 58-64.
213. Sandberg, M., Butcher, P. S. and Hagberg, H. (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem. 47, 178-184.
214. Saugstad, J. A., Kinzie, J. M., Mulvihill, E. R., Segerson, T. P. and Westbrook, G. L. (1994) Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors. Mol. Pharmacol. 45, 367-372.
215. Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Calrk, J. B. and Marsden, C. D. (1989) Mitochondrial complex 1 deficiency in Parkinson's disease. Lancet 1, 1269.
216. Schapira, A.H.V., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. and Marsden, C.D. (1990a) Mitochondrial complex 1 deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
217. Schapira, A.H.V., Mann, V.M., Cooper, J.M., Dexter, D., Daniel, S.E., Jenner, P., Clark, J.B. and Marsden, C.D. (1990b) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
218. Schulz, J. B., Henshaw, D. R., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Rosen, B. R. and Beal, M. F. (1994) 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum. J. Cereb. Blood Flow Metab. 14, 1024-1029.
219. Schulz, J.B., Henshaw, D.R., Matthews, R.T. and Beal, M.F. (1995a) Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp. Neurol. 132, 279-283.
220. Schulz, J.B., Henshaw, D.R., Siwek, D., Jenkins, B.G., Ferrante, R.J., Cipolloni, P.B., Kowall, N.W., Rosen, B.R. and Beal, M.F. (1995b) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 63, 2239-2247.
221. Schulz, J.B., Matthews, R.T., Muqit, M.M.K., Browne, S.E. and Beal, M.F. (1995c) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
222. Sheardown, M. J., Nielsen, E. Ø., Hansen, A. J., Jacobsen, P. and Honoré, T. (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247, 571-574.
223. Sheu, K. F., Kim, Y. T., Blass, J. P. and Weksler, M. E. (1985) An immunohistochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17, 444-449.
224. Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A. and Wallace, D. C. (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30, 332-339.
225. Silverstein, F. S., Buchanan, M. and Johnston, M. V. (1986) Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J. Neurochem. 47, 1614-1619.
226. 14C]glucose in vitro in human neocortex. J. Neurochem. 41, 1329-1334.
227. Slater, E. C. (1973) The mechanism of action of the respiratory inhibitor, antimycin. Biochim. Biophys. Acta 301, 129-154.
228. Sommer, B., Keinanen, K., Verdoon, T. A., Wisden, W., Burnashev, N., Herb, A., Köhler, M., Takagi, T., Sakmann, B. and Seeburg, P. H. (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249, 1580-1585.
229. Sonsalla, P. K., Zeevalk, G. D., Manzino, L., Giovanni, A. and Nicklas, W. J. (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem. 58, 1979-1982.
230. Sorbi, S., Bird, E. D. and Blass, J. P. (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72-78.
231. Sorbi, S., Mortilla, M., Piacentini, S., Tonini, S. and Amaducci, L. (1990) Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients. Neurosci. Lett. 117, 165-168.
232. Steinberg, G. K., Yoon, E. J., Kunis, D. M., Sun, G. H., Maier, C. M. and Grant, G. A. (1994) Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing. Neuroscience 64, 99-107.
233. Storey, E., Hyman, B. T., Jenkins, B., Brouillet, E., Miller, J. M., Rosen, B. R. and Beal, M. F. (1992) 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58, 1975-1978.
234. Stryer L. (1988) In: Biochemistry, pp. 349-426. W. H. Freeman and Company, New York.
235. 2+ exchanger. J. Neurosci. 12, 430-439.
236. Sucher, N. J., Akbarian, S., Chi, C. L., Leclerc, C. L., Awobuluyi, M., Deitcher, D. L., Wu, M. K., Yuan, J. P., Jones, E. G. and Lipton, S. A. (1995) Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDA-L) in the rodent brain. J. Neurosci. 15, 6509-6520.
237. Szatkowski, M., Barbour, B. and Atwell, D. (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348, 443-446.
238. Tanabe, S., Masu, M., Ishii, T., Shigemoto, R. and Nakanishi, S. (1992) A family of metabotropic glutamate receptors. Neuron 8, 169-172.
239. Tang, C.-M., Dichter, M. and Morad, M. (1990) Modulation of the N-methyl-D-aspartate channel by extracellular H +. Proc. Natl. Acad. Sci. USA 87, 6445-6449.
240. Thayer, S. A. and Miller, R. J. (1990) Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J. Physiol. (Lond.) 425, 85-115.
241. Traynelis, S. F. and Cull-Candy, S. G. (1990) Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345, 347-350.
242. + sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurons. J. Physiol. (Lond.) 433, 727-763.
243. Traynelis, S. F., Hartley, M. and Heinemann, S. F. (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876.
244. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-418.
245. Tymianski, M., Charlton, M. P., Carlen, P. L. and Tator, C. H. (1993) Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13, 2085-2104.
246. Uemura, Y., Kowal, N. W. and Beal, M. F. (1990) Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27, 620-625.
247. Urbanska, E., Ikonomidou, C., Sieklucka, M. and Turski, W. A. (1991) Aminooxyacetic acid produces excitotoxic lesions in the rat striatum. Synapse 9, 129-135.
248. Vyklicky, L., Vlachova, V. and Krusek, J. (1990) The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J. Physiol. (Lond.) 430, 497-517.
249. Wallace, M. C., Teasdale, G. M. and McCulloch, J. (1992) Autoradiographic analysis of 3HMK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat. J. Neurosurg. 76, 127-133.
250. Watkins, J. C. and Evans, R. H. (1981) Excitatory amino acid transmitters. A. Rev. Pharmacol. Toxicol. 21, 165-204.
251. Weller, M. and Paul, S. M. (1993) 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons. Eur. J. Pharmacol. 248, 223-228.
252. Werner, P., Voigt, M., Keinanen, K., Wisden, W. and Seeburg, P. H. (1991) Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature 351, 742-744.
253. Werth, J. L. and Thayer, S. A. (1994) Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J. Neurosci. 14, 348-358.
254. 2+ antagonise NMDA and GABA responses of hippocampal neurons. Nature 328, 640-643.
255. Westerlink, B. H. C., Damsma, G. and De Vries, J. B. (1989) Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats. J. Neurochem. 52, 705-712.
256. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J. Neurosci. 15, 1318-1328.
257. Whittam, R. (1962) The dependence of the respiration of brain cortex on active cation transport. Biochem. J. 82, 205-212.
258. Wieloch, T. (1985) Hypoglycemia-induced neuronal damage prevented by and N-methyl-D-aspartate antagonist. Science 230, 681-683.
259. Wieloch, T., Harris, R. J., Symon, L. and Siesjö, B. K. (1984) Influence of severe hypoglycemia on brain extracellular calcium and potassium activities, energy, and phospholipid metabolism. J. Neurochem. 43, 160-168.
260. Williams, K., Romano, C., Dichter, M. A. and Molinoff, P. B. (1991) Modulation of the NMDA receptor by polyamines. Life Sci. 48, 469-498.
261. Wüllner, U., Young, A. B., Penney, J. B. and Beal, M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 1772-1781.
262. Yarowsky, P. J. and Ingvar, D. H. (1981) Neuronal activity and energy metabolism. Fed. Proc. 40, 2353-2362.
263. Yoshino, H., Nakagawa-Hattori, Y., Kondo, T. and Uno, Y. (1992) Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J. Neural Trans. (Parkinson's Disease and Dementia Section) 4, 27-34.
264. Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I. and Penney, J. B. (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241, 981-983.
265. Yue, T.-L., Gu, J.-L., Lysko, P. G., Cheng, H.-Y., Barone, F. C. and Feuerstein, G. (1992) Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global ischemia and in cultured rat cerebellar neurons. Brain Res. 574, 193-197.
266. Zeevalk, G. D., Derr-Yellin, E. and Nicklas, W. J. (1995) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64, 455-458.
267. Zeevalk, G. D. and Nicklas, W. J. (1990) Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253, 1285-1292.
268. Zeevalk, G. D. and Nicklas, W. J. (1991) Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmacol. Exp. Ther. 257, 870-878.
269. 2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Neurochem. 59, 1211-1220.
270. Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F. and Corsini, G. U. (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J. Neurochem. 59, 733-739.